Inflammation  >>  Careram (iguratimod)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Careram (iguratimod) / Eisai, R-Pharm
NCT03368274: To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom

Unknown status
4
30
RoW
T 614, diprospan
Wen Zhang
IgG4-related Disease
06/18
06/18
NCT05626348: The Clinical Efficacy of Immunomodulators in RA Patients

Recruiting
4
400
RoW
Iguratimod, IGU, T-614, Methotrexate, MTX, Adalimumab Injection, adalimu, Leflunomide, LEF, Hydroxychloroquine, HCQ
Qilu Hospital of Shandong University
Arthritis, Rheumatoid
06/25
12/26

Download Options